EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Predicting new-onset major depressive disorder in diffuse large B-cell lymphoma via machine learning: insights into neuro-immune interactions using SHAP

Ke Yan, Li Chen, Xuxiong Liao, Yun Han, Kai Zhou, Yu Song, Ling Tang, Yaqin Li

Frontiers in Psychiatry · 20.11.2026 · 17

DOI: 10.3389/fpsyt.2026.1868471 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Psychiatry, online erschienen am 20.11.2026. Verfasst von Ke Yan und 7 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Major depressive disorder (MDD) frequently complicates the clinical course of diffuse large B-cell lymphoma (DLBCL). This study aimed to develop machine learning models to predict new-onset MDD during treatment and to i explore hypothesis-generating neuro-immune predictive associations using SHAP analysis.

Methods

A retrospective cohort of 526 DLBCL patients was analyzed. Fifteen baseline variables were utilized to train and evaluate six predictive algorithms. SHAP dependence and individual conditional expectation analyses were applied to explore multidimensional feature interactions.

Results

The Random Forest model demonstrated superior predictive performance in the testing set (AUC = 0.913, 95% CI: 0.858-0.968; Brier score = 0.124). SHAP analysis indicated that constitutional symptom burden (B symptoms), systemic inflammation (IL-6), baseline subclinical depressive symptoms (PHQ-9 score), tumor burden (LDH), and endocrine stress (morning cortisol) were the top five predictive features associated with model-estimated MDD risk. Exploratory dependence and interaction analyses suggested non-linear inflection patterns and statistical interactions, where concurrent elevations in IL-6 and cortisol were associated with higher predicted probabilities.

Conclusions

Machine learning approaches may facilitate early risk estimation for MDD in DLBCL patients. The identified neuro-immune associations warrant further prospective validation to evaluate their clinical utility.

Zitieren

APA

Yan, K., Chen, L., Liao, X., Han, Y., Zhou, K., Song, Y., Tang, L., & Li, Y. (2026). Predicting new-onset major depressive disorder in diffuse large B-cell lymphoma via machine learning: insights into neuro-immune interactions using SHAP. Frontiers in Psychiatry, 17. https://doi.org/10.3389/fpsyt.2026.1868471

Vancouver

Yan K, Chen L, Liao X, Han Y, Zhou K, Song Y, et al. Predicting new-onset major depressive disorder in diffuse large B-cell lymphoma via machine learning: insights into neuro-immune interactions using SHAP. Frontiers in Psychiatry. 2026;17. doi:10.3389/fpsyt.2026.1868471

BibTeX
@article{Yan2026,
  author = {Yan, Ke and Chen, Li and Liao, Xuxiong and Han, Yun and Zhou, Kai and Song, Yu and Tang, Ling and Li, Yaqin},
  title = {Predicting new-onset major depressive disorder in diffuse large B-cell lymphoma via machine learning: insights into neuro-immune interactions using SHAP},
  journal = {Frontiers in Psychiatry},
  year = {2026},
  volume = {17},
  doi = {10.3389/fpsyt.2026.1868471}
}
Kostenlos starten →